Cargando…
Development of a core outcome set for myocardial infarction in clinical trials of traditional Chinese medicine: a study protocol
INTRODUCTION: Myocardial infarction (MI) is the most dangerous complication in patients with coronary heart disease. In China, there is an increasing number of randomised controlled trials (RCTs) of traditional Chinese medicine (TCM) for treating MI. However, the inconsistency of outcome reporting m...
Autores principales: | Qiu, Ruijin, Zhong, Changming, Han, Songjie, He, Tianmai, Huang, Ya, Guan, Manke, Hu, Jiayuan, Li, Min, Lin, Yiyi, Chen, Jing, Shang, Hongcai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924774/ https://www.ncbi.nlm.nih.gov/pubmed/31796484 http://dx.doi.org/10.1136/bmjopen-2019-032256 |
Ejemplares similares
-
Outcome reporting from clinical trials of non-valvular atrial fibrillation treated with traditional Chinese medicine or Western medicine: a systematic review
por: Qiu, Ruijin, et al.
Publicado: (2019) -
Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine
por: Qiu, Ruijin, et al.
Publicado: (2020) -
Development of a Core Outcome Set for the Benefits and Adverse Events of Acute Heart Failure in Clinical Trials of Traditional Chinese Medicine and Western Medicine: A Study Protocol
por: Qiu, Ruijin, et al.
Publicado: (2021) -
Quality assessment of clinical trial registration with traditional Chinese medicine in WHO registries
por: Zhang, Xuan, et al.
Publicado: (2019) -
Development of CORE-CM core outcome domain sets for trials of Chinese medicine for lumbar spinal stenosis
por: Sun, Ya-Nan, et al.
Publicado: (2023)